Biotech

All Articles

Vaxcyte rises on 'stunning' 31-valent PCV gain versus Pfizer

.Vaxcyte revealed what analysts referred to as "stunning" stage 1/2 data for its 31-valent pneumococ...

Recursion's human brain health condition test shows little evidence of efficacy

.Recursion has stumbled via a very early exam of its own tech-enabled strategy to medicine explorati...

Acepodia, Pfizer click all together for chemistry-based cell therapy

.Call it a case of good chemical make up: Acepodia, a biotech based upon Nobel Champion science, is ...

Praxis epilepsy medicine decreases confiscations in phase 2 litigation

.Practice Precision Medicines has actually racked up another midphase win in epilepsy this year, alo...

Three execs surrender as Dyne blog posts mixed information for DMD applicant

.After running away a professional grip numerous years back, Dyne Rehab has actually disclosed brand...

Arrowhead fires off stage 3 information in unusual metabolic health condition in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has actually shown its hand in front of a prospective face-off with Ionis...

Pfizer, Valneva present lyme health condition chance reliable for second enhancer

.Pfizer and also Valneva might possess concerning 2 more years to wait before they help make the 1st...

Fierce Biotech Managing Editor Ayla Ellison Chats Shop with Michelle Benz on the Future of Biotech.

.Permit's study a conversation along with Ayla Ellison, Ferocious Biotech Managing Editor and Michel...

New information show how Bayer's asundexian stopped working to avoid strokes

.Bayer put on hold the period 3 trial for its aspect XIa inhibitor asundexian behind time in 2013 af...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS trials

.Sanofi is actually still set on taking its multiple sclerosis (MS) med tolebrutinib to the FDA, exe...